Clinical Trial Update: TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating TVB-2640 in combination with bevacizumab in first relapse high-grade astrocytoma (astrocytoma). Status completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• TVB-2640

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Astrocytoma | Phase 2 | Status: COMPLETED | Results posted: 2023-06-15